Advertisement
Screener

DEXCOM, INC. (DXCM) Information Technology and Data Processing

2.8 / 5 stars · 68/120 Roast Me

DEXCOM, INC. Information Technology and Data Processing

DEXCOM, INC. (DXCM) reported Information Technology and Data Processing of $40.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:InformationTechnologyAndDataProcessing · last filed 2026-07-30

  • DEXCOM, INC. information technology and data processing for the quarter ending 2026-06-30 was $40.00M, a 11.11% increase year-over-year.
  • DEXCOM, INC. information technology and data processing for the quarter ending 2026-03-31 was $38.30M, a 9.12% increase year-over-year.
  • DEXCOM, INC. information technology and data processing for the quarter ending 2025-12-31 was $36.40M, a 7.06% increase year-over-year.
  • DEXCOM, INC. information technology and data processing for the quarter ending 2025-09-30 was $36.80M, a 10.84% increase year-over-year.
  • DEXCOM, INC. information technology and data processing for fiscal 2025 was $144.30M, a 10.49% increase from fiscal 2024.
  • DEXCOM, INC. information technology and data processing for fiscal 2024 was $130.60M, a 22.51% increase from fiscal 2023.
  • DEXCOM, INC. information technology and data processing for fiscal 2023 was $106.60M, a 23.24% increase from fiscal 2022.
  • DEXCOM, INC. information technology and data processing for fiscal 2022 was $86.50M.
Period endInformation Technology and Data Processing 3 monthInformation Technology and Data Processing 6 monthInformation Technology and Data Processing 9 monthInformation Technology and Data Processing 12 month
2026-06-30$40.00M
10-Q · filed 2026-07-30
$78.30M
10-Q · filed 2026-07-30
$114.70M
derived: sum of 3 quarters · filed 2026-07-30
$151.50M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$38.30M
10-Q · filed 2026-04-30
$74.70M
derived: sum of 2 quarters · filed 2026-04-30
$111.50M
derived: sum of 3 quarters · filed 2026-04-30
$147.50M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$36.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$73.20M
derived: sum of 2 quarters · filed 2026-02-12
$109.20M
derived: sum of 3 quarters · filed 2026-07-30
$144.30M
10-K · filed 2026-02-12
2025-09-30$36.80M
10-Q · filed 2025-10-30
$72.80M
derived: sum of 2 quarters · filed 2026-07-30
$107.90M
10-Q · filed 2025-10-30
$141.90M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$36.00M
10-Q · filed 2026-07-30
$71.10M
10-Q · filed 2026-07-30
$105.10M
derived: sum of 3 quarters · filed 2026-07-30
$138.30M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$35.10M
10-Q · filed 2026-04-30
$69.10M
derived: sum of 2 quarters · filed 2026-04-30
$102.30M
derived: sum of 3 quarters · filed 2026-04-30
$133.60M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$34.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$67.20M
derived: sum of 2 quarters · filed 2026-02-12
$98.50M
derived: sum of 3 quarters · filed 2026-02-12
$130.60M
10-K · filed 2026-02-12
2024-09-30$33.20M
10-Q · filed 2025-10-30
$64.50M
derived: sum of 2 quarters · filed 2025-10-30
$96.60M
10-Q · filed 2025-10-30
2024-06-30$31.30M
10-Q · filed 2025-07-30
$63.40M
10-Q · filed 2025-07-30
2024-03-31$32.10M
10-Q · filed 2025-05-01
2023-12-31$106.60M
10-K · filed 2026-02-12
2022-12-31$86.50M
10-K · filed 2025-02-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44